Guide to buying Eli Lilly stock in Canada

Learn how to buy Eli Lilly stock in Canada, and how to decide if LLY stock is a buy or sell with detailed price, chart and performance metrics.

Eli Lilly is a drug manufacturers - general business based in the US. Eli Lilly stocks (LLY) are listed on the NYSE, and all prices are listed in US Dollars.

Eli Lilly employs 47,000 staff and has a trailing 12-month revenue of around $59.4 billion.

Keep reading to see up-to-date Eli Lilly stock price and performance data, along with a step-by-step guide for how to buy Eli Lilly stock in Canada.

Eli Lilly (LLY) stock summary

Company stock name Eli Lilly and Company
Stock ticker symbol LLY
Exchange NYSE
52-week stock price range $621.50 – $1,111.99
Where to buy Eli Lilly stock Buy on CIBC Investor's Edge
All amounts in this table are in USD.

Can I buy Eli Lilly stock in Canada?

Yes, you can buy Eli Lilly stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NYSE exchange. Platforms like Interactive Brokers will allow you to directly buy Eli Lilly stock from within Canada.

How to buy Eli Lilly stock

Follow these step-by-step instructions to purchase Eli Lilly (LLY) stock in Canada:
  1. Choose a stock trading platform.
    Compare trading platforms. Choose a trading app with competitive pricing, access to trading tools and a user-friendly interface. (Check out our guide to the best trading apps in Canada.)
  2. Open a trading account.
    To open a trading account, you'll need to provide personal information (like your email, phone number and banking details), verify your identity and complete the sign-up process.
  3. Fund your account.
    Deposit funds into your trading account by linking your bank account via an Electronic Funds Transfer (EFT), wire transfer, cheque deposit or by whatever means the platform supports. Make sure you deposit enough to cover the stock price + any trading fees.
  4. Search for the stock—LLY.
    Look up the stock using its name (Eli Lilly and Company) or ticker symbol (LLY). Review its current price, recent performance and other relevant data before placing your order.
  5. Complete your purchase of Eli Lilly stock.
    Choose the number of LLY stocks you want to purchase, place your order, confirm the details and then submit. Once executed, the shares will appear in your trading account.

Our top picks for where to buy Eli Lilly and Company stock

Best for Beginners

Easy to use app
  • Easy-to-use platform
  • Low fees
  • Student, young investor & active trader discounts

Low Margin Rates

Low margin rates
  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Best for Low Fees

CA & US trading
  • Up to $4,600 in trading perks
  • Low transaction fees
  • Easy-to-use app

Eli Lilly stock chart (NYSE: LLY)

This chart tracks Eli Lilly stock price performance over time.

Eli Lilly stock price

We'll update this guide as more Eli Lilly stock information becomes available.

Is Eli Lilly stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for Eli Lilly stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy Eli Lilly stock on the TSX?

No, you cannot buy Eli Lilly stock on the TSX because Eli Lilly stock is not listed on the TSX. Instead, Eli Lilly stock is listed on the NYSE under the symbol "LLY."

That said, if you're wondering how to invest in Eli Lilly stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Interactive Brokers.

Eli Lilly stock dividends

27%

Eli Lilly dividend payout ratio: 27.29% of net profits

Recently Eli Lilly has paid out, on average, around 27.29% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.56% of the current stock value.

This means that, over a year, based on recent payouts (which are sadly no guarantee of future payouts), Eli Lilly shareholders could enjoy a 0.56% return on their shares in the form of dividend payments. In Eli Lilly's case, that would currently equate to about $5.80 per share.

While Eli Lilly's payout ratio might seem fairly standard, it's worth remembering that Eli Lilly may be investing much of the rest of its net profits in future growth.

Eli Lilly's next dividend payout is expected around December 10, 2025. To benefit, you'll need to buy Eli Lilly stocks before November 14, 2025 (the "ex-dividend date").

Eli Lilly stock performance metrics

Here are some common key metrics for Eli Lilly stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

Has Eli Lilly stock ever split?

Eli Lilly's stocks were split on a 2:1 basis on October 15, 1997. So, if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Eli Lilly stocks, just the quantity.

However, indirectly, the new 50% lower stock price could have impacted the market appetite for Eli Lilly stocks, which in turn could have impacted Eli Lilly's stock price.

How volatile is Eli Lilly stock?

Over the last 12 months, Eli Lilly's stocks price has ranged from $621.50 to as high as $1,111.99. Eli Lilly's beta measurement of stock volatility is 0.39. For comparison, the market () average beta is 1. This would suggest that Eli Lilly's stocks are less volatile than average (on this exchange).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of Eli Lilly's beta stock volatility rating.

Eli Lilly and Company company and revenue performance

Market Capitalization $948.4 billion
Gross profit (TTM) $49.3 billion
Operating margin (TTM) 48.29%
Profit margin 30.99%
Revenue (TTM) $59.4 billion
Return on assets (TTM) 17.60%
Return on equity (TTM) 96.47%
Earnings per share (TTM) $20.60
50-day moving stock price average $888.61
200-day moving stock price average $808.62
All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on December 4, 2025.

Eli Lilly company profile

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache.

It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd; Strategic Collaboration with Eli Lilly to advance development of its myeloid engager platform for autoimmune disease, as well as Strategic partnership with NVIDIA Corporation.

The company also has a research collaboration agreement with Insilico Medicine for the development of advance therapies.

Compare trading platforms to buy Eli Lilly and Company stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

5 of 5 results
Finder Score Available Asset Types Account Types Stock Trading Fee Monthly Account Fee
Finder Score
Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures
RRSP, TFSA, Personal, Joint
min $1.00, max 0.5%
$0
Go to site More info
Compare product selection
CIBC logo
Finder Score
Finder Score
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint, Business, FHSA
$6.95
$0 if conditions met, or $100
Get 100 free online stock and ETF trades when you open a new account & get up to $15,000 in cashback when you transfer funds from outside CIBC to your new or existing account. Valid until March 31, 2026. T&Cs apply.
Go to site More info
Compare product selection
Moomoo logo
Finder Score
Finder Score
Stocks, Options, ETFs
RRSP, TFSA, Personal, FHSA
$1.49/stock
$0
Get up to $4,600 in trading perks. T&Cs apply.
Go to site More info
Compare product selection
Qtrade logo
Finder Score
Finder Score
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA
$0
$0
Get 5% cash back on every dollar you invest up to $15,000 and 1% cash back on any amount above that. Plus, new clients receive unlimited free trades. Use code QTRADE2025. Valid until January 5, 2026. T&Cs apply.
Go to site More info
Compare product selection
Questrade logo
Finder Score
Finder Score
Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA
$0
$0
Get free contracts, no commissions and a 30 day free trial of Questrade Plus. Use offer code FREEOPTIONS. T&Cs apply.
Go to site More info
Compare product selection
loading
Showing 5 of 5 results

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

Read the full methodology

Do I have to pay tax on gains from Eli Lilly stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Eli Lilly stock. The CRA taxes investment income from stocks in Canada based on three main factors:

  1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
  2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
  3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about Eli Lilly stock

Sources

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.

More guides on Finder

Go to site